世界の経腸ステント市場の規模、シェア、トレンド分析レポート – 業界の概要と2032年までの予測

経腸ステント市場分析

経腸ステント市場では、材料、設計、および送達技術の面で大きな進歩が見られました。最近の技術革新には、柔軟性、強度、および生体適合性を向上させる先進合金から作られた生体適合性の自己拡張型金属ステントの開発が含まれます。これらのステントは、詰まりや移動に抵抗するように設計されており、患者の転帰を改善します。

生分解性腸管ステントの導入も大きな進歩です。これらのステントは目的を果たした後に自然に分解されるため、除去処置の必要性が減り、長期的な合併症のリスクが最小限に抑えられます。さらに、内視鏡や蛍光透視ガイドなどの画像技術の進歩により、ステントをより正確に配置できるようになり、その有効性が向上しています。

経腸ステント市場の成長は、食道がんなどの消化器疾患の罹患率の上昇と、低侵襲治療に対する意識の高まりによって推進されています。高齢化人口が増加し、医療提供者が患者の生活の質の向上に注力するにつれて、経腸ステントの需要は高まり続けています。技術の向上と治療結果の改善により、今後数年間で市場がさらに成長すると予想されます。

経腸ステント市場規模

世界の経腸ステント市場規模は、2024年に23億9,000万米ドルと評価され、2025年から2032年の予測期間中に6.28%のCAGRで成長し、2032年までに38億9,000万米ドルに達すると予測されています。市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、Data Bridge Market Researchがまとめた市場レポートには、詳細な専門家分析、患者の疫学、パイプライン分析、価格分析、規制枠組みも含まれています。

経腸ステント市場の動向

「低侵襲手術の需要が高まる」

経腸ステント市場の成長を牽引する主な傾向は、低侵襲処置への嗜好の高まりです。消化管閉塞の治療に使用される経腸ステントは、大がかりな手術を必要とせずに痛みを和らげるために不可欠です。回復時間の短縮や入院期間の短縮など、これらの処置の利点に対する認識が高まっていることが、市場の需要を後押ししています。たとえば、世界中の病院や診療所は、食道がんやクローン病などの症状を持つ患者にとって、より迅速で外傷の少ない選択肢となるため、外科的バイパス処置よりもステント留置術を採用しています。この低侵襲治療へのシフトにより、経腸ステントの採用が加速し、市場拡大に大きく貢献すると予想されます。

レポートの範囲と経腸ステント市場のセグメンテーション       

経腸ステント市場の定義

腸管ステントは、食道、十二指腸、結腸などの消化管の閉塞や狭窄を治療するために使用される医療機器です。通常、金属やシリコンなどの材料で作られており、通路を開いたままにするために患部に挿入されるように設計されています。これにより、食物、液体、または老廃物の流れが維持され、患者の食事と消化能力が向上します。腸管ステントは、がん、クローン病、またはその他の胃腸障害などの症状を持つ患者によく使用され、手術よりも侵襲性の低い代替手段を提供し、全体的な生活の質を向上させます。

経腸ステント市場の動向

ドライバー

• 消化器疾患の罹患率の増加

大腸がん、食道がん、クローン病などの消化器疾患の増加は、経腸ステント市場の大きな推進力となっています。これらの疾患は、消化管の閉塞につながることが多く、食物や液体の適切な通路を回復するための介入が必要となります。例えば、腫瘍が食道を塞ぐ食道がん患者の場合、嚥下のための通路を確保するために経腸ステントが使用され、患者の生活の質が向上します。同様に、大腸がんやクローン病の場合、症状を緩和し、外科手術を回避するためにステントが使用されます。これらの疾患が世界的に増加するにつれて、非外科的解決策としての経腸ステントの需要は高まり続け、市場拡大を後押ししています。

• 緩和ケアの需要の高まり

緩和ケア、特に腫瘍学における関心の高まりが、経腸ステント市場を牽引しています。経腸ステントは、食道または胃腸の閉塞の緩和など、末期がん患者の症状管理によく使用されます。この緩和的アプローチは、根治手術の対象ではない患者の生活の質の向上に役立ちます。たとえば、進行した食道がんの患者では、嚥下機能を回復し、症状を緩和するために自己拡張型金属ステントが頻繁に使用されます。がん治療における緩和ケアの重要性の認識が高まり、人口の高齢化とがん罹患率の上昇が相まって、この状況での経腸ステントの需要増加に大きく貢献しています。

機会

• ステント材料の進歩

The development of biocompatible and durable materials has created significant opportunities in the enteral stents market. Innovations such as self-expanding metal stents (SEMS) made from alloys such as nitinol offer superior flexibility, durability, and resistance to corrosion. In addition, the emergence of biodegradable stents made from materials such as polylactic acid (PLA) provides a temporary solution, reducing the need for removal procedures. These advancements not only enhance the effectiveness of stents but also minimize complications such as infection and blockage. For instance, the use of coated stents in treating esophageal cancer has improved outcomes by reducing tumor ingrowth and migration, thereby increasing the market demand for such advanced stent technologies.

• Government Initiatives for Cancer Treatment

Government initiatives aimed at improving cancer care are creating significant opportunities in the enteral stents market. With an increasing focus on offering better treatment options, many governments have been funding advanced therapies for cancer patients, including minimally invasive solutions such as enteral stents. For instance, According to the World Health Organization 2023, colorectal cancer is the third most common cancer, responsible for about 10% of all cases and the second leading cause of cancer-related deaths worldwide. The Global Cancer Observatory reported nearly 1.15 million new cases in 2020, with projections estimating around 1.92 million new cases globally by 2040.

Restraints/Challenges

• Cost and Reimbursement Issues

Cost and reimbursement issues significantly hinder the enteral stents market. The high cost of these devices can be a major barrier, particularly in healthcare systems with limited budgets or price-sensitive populations. In many regions, reimbursement policies for enteral stents are restrictive or inadequate, leading to patients being unable to afford the procedure. Healthcare systems may not fully cover the expenses, forcing patients to either bear the cost themselves or forgo treatment altogether. This results in reduced adoption rates, limiting the growth potential of the market. In addition, hospitals and healthcare providers may be hesitant to invest in expensive stents without adequate financial support or reimbursement assurances.   

• Chances of Complications and Risks

The chances of complications and risks associated with enteral stents significantly hinder market growth. Migration of stents, perforation of the gastrointestinal tract, and infections are common issues that can arise after stent placement. These complications often necessitate additional medical interventions, leading to longer hospital stays and increased healthcare costs. Furthermore, the need for follow-up procedures or removal of the stents can contribute to patient discomfort and prolong recovery times. Such risks deter both healthcare providers and patients from opting for enteral stents, leading to a decline in adoption rates. As a result, these complications pose a substantial challenge to the growth of the enteral stents market.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Enteral Stents Market Scope

The market is segmented on the basis of product type, stent type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Stent Type

• Esophageal Stents
• Gastroduodenal Stents
• Colon Stents
  • Pre-Operative Decompression
  • Palliation of Advanced Malignancy

 Product Type

• Self-Expandable Metal Stents (SEMS)
  • Uncovered SEMS
  • Partially Covered SEMS
  •  Fully Covered SEMS
• Self-Expandable Plastic Stents (SEPS)

 End User

• Hospitals
• Specialty Clinics
• Ambulatory Centers
• Research Centers

Enteral Stents Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, product type, stent type and end user as referenced above.

The countries covered in the market report are U.S., Canada, Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Brazil, Argentina, Rest of South America as a part of South America, U.A.E, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA)

North America is expected to dominate the enteral stents market due to technological advancements, a rising prevalence of cancer, and lifestyle changes in the region. The growing demand for minimally invasive procedures and improved healthcare infrastructure further boosts the adoption of enteral stents, positioning North America as the leading market player.

Asia-Pacific is expected to grow at the highest growth rate in the enteral stents market during the forecast period. This growth is driven by advancements in healthcare infrastructure, increasing per capita healthcare expenditure, and rising demand for minimally invasive procedures, particularly in countries such as China and India.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Enteral Stents Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Enteral Stents Market Leaders Operating in the Market Are:

• Boston Scientific Corporation (U.S.)
• Cook (U.S.)
• Abbott (U.S.)
• Biosensors International Group, Ltd. (Singapore)
• Stryker (U.S.)
• Medtronic (U.S.)
• B. Braun SE (Germany)
• BD (U.S.)
• Cardinal Health (U.S.)
• Terumo Europe NV (Belgium)
• TAEWOONG (South Korea)
• ELLA - CS, s.r.o. (Czech Republic)
• Merit Medical Systems (U.S.)
• M.I.TECH. (South Korea)
• BVM Medical Limited (U.K.)
• Changzhou Health Microport Medical Device Co., LTD. (China)
• ENDO-FLEX GmbH (Germany)
• Micro-Tech (Nanjing) Co., Ltd. (China)
• GBUK Group Ltd. (U.K.)

Latest Developments in Enteral Stents Market

• In November 2022, The Union Health Ministry of India announced the inclusion of coronary stents in the National List of Essential Medicines 2022. This decision was aimed at making coronary stents more affordable for the Indian population, thereby improving access to life-saving treatments for heart conditions and enhancing overall cardiovascular care across the country
• In May 2022, Medtronic received approval from the US FDA for the Onyx Frontier drug-eluting stent (DES), a significant advancement in cardiovascular treatment. This stent features a unique design to enhance the safety and effectiveness of heart procedures, offering improved clinical outcomes for patients suffering from coronary artery disease, with a focus on long-term performance
• In April 2022, Translumina, a prominent manufacturer of cardiovascular medical devices, launched its innovative VIVO ISAR dual drug polymer-free coated stent (DDCS) in international markets, including Europe. The stent offers improved drug delivery and vascular healing, providing an alternative to traditional drug-eluting stents and enhancing treatment options for patients undergoing interventional cardiology procedures globally
• In October 2020, Olympus, a leader in medical technologies, launched the HANAROSTENT Esophagus TTS self-expanding metal stents (SEMS) in the US. Manufactured by M.I. Tech and distributed exclusively through Olympus, these stents are designed for treating esophageal conditions, offering a reliable solution for physicians to manage obstructive and malignant conditions in the esophagus, improving patient care and quality of life

SKU-59921